Mereo Biopharma Group PLC - American Depositary Shares (MREO) closed at $0.31 on November 16, 2026, down 1.0% from the previous close, on volume of 614,708 shares (30-day average 808,839).
Data as of November 16, 2026.
Mereo BioPharma Reports Third Quarter 2026 Financial Results
Globe Newswire (Mon, 9-Nov 8:00 AM ET)
Mereo BioPharma’s Alvelestat Deal and Improved Cash Runway Pave Path for 2027 Growth
Market Chameleon (Tue, 11-Aug 5:55 AM ET)
Mereo BioPharma Extends Cash Runway to Mid-2027 Amid Mixed Setrusumab Phase 3 Results
Market Chameleon (Mon, 12-Jan 5:31 AM ET)
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Mereo Biopharma Group PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol MREO.
As of November 17, 2026, MREO stock price declined to $0.27 with 880,043 million shares trading.
MREO has a beta of 2.78, meaning it tends to be more sensitive to market movements. MREO has a correlation of 0.04 to the broad based SPY ETF.
MREO has a market cap of $43.10 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, MREO traded as high as $5.02 and as low as $.20.
MREO has underperformed the market in the last year with a price return of -84.8% while the SPY ETF gained +9.9%. MREO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.3% and -6.9%, respectively, while the SPY returned -5.6% and -2.9%, respectively.
MREO support price is $.29 and resistance is $.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MREO shares will trade within this expected range on the day.